FLT4 and neoplasm: Anti-VEGFR2 and anti-VEGFR3 Dox loaded immunoliposomes are common examples that have resulted in greater reduction in tumor mass in animal studies using antibodies against vascular endothelial growth factor receptors for targeting tumor-associated neovascular endothelial cells [77].